Quick Answer
ProQR Therapeutics N.V. reported Total Assets of $112.76 million for fiscal year 2025.
ProQR Therapeutics N.V. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $112.76M | -32.9% |
| 2024 | $167.96M | +21.8% |
| 2023 | $137.88M | -19.5% |
| 2022 | $171.32M | -18.3% |
| 2021 | $209.58M | +112.3% |
| 2020 | $98.73M | -16.0% |
| 2019 | $117.53M | +6.6% |
| 2018 | $110.23M | +107.6% |
| 2017 | $53.10M | -19.0% |
| 2016 | $65.54M | — |
- ProQR Therapeutics N.V. showed a decrease of -32.9% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, ProQR Therapeutics N.V.’s total assets has grown by 72.0% (from $65.54 million to $112.76 million).
- The most recent figure is from ProQR Therapeutics N.V.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: